Maz Ganat, MD

Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

About Maz Ganat

Dr. Ganat, Program Director of Urologic Oncology at Englewood Hospital, specializes in cancers of the prostate, bladder, kidney, testes, and penis and performs both open and robotic surgeries. He obtained his MD from SUNY Downstate College of Medicine and did his internship in surgery and residency in urology at SUNY Downstate Medical Center. Following his residency, Dr. Ganat completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a member of the American Urological Association and the Society of Urologic Oncology. Dr. Ganat's research interests are the immunogenomics of urologic malignancies and precision medicine.

Honors & Awards

2020, 2019: Bergen Magazine Top Doctors

Arnold P. Gold Foundation Humanism Award

Professional Memberships

American Urological Association

Society of Urologic Oncology

Publications

Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, andNielsen J. Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cellcarcinoma. Accepted to European Urology Oncology. May 2018

Mendonca S, Sanchez A, Blum K, Ghanaat M, Kashan M, Becerra M, Manley B, Benfante N, Russo P, Coleman J,Crago A, Hakimi AA The Association of Renal Cell Carcinoma with Gastrointestinal Stromal Tumors. The Journal ofSurgical Oncology. Accepted March, 2018 In Press

Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra M, Manley BJ, Casuscelli J,Chiok M, Tikoo S, Akin O, Coleman JA, Russo P, Hakimi AA. Cystic renal cell carcinoma: a report on outcomes ofsurgery and active surveillance in patients retrospectively identified on pretreatment imaging. The Journal of Urology. 2018 Feb 26.

Comparison of Postoperative Ileus Rates Using GIA-80 versus GIA-60 Intestinal Stapler Device after RadicalCystectomy. Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Dalbagni G, HerrHW, Bochner BH, Vickers AJ, and Donat SM. Submitted.

Characterizing Recurrent and Lethal Small Renal Masses in Clear Cell Renal Cell Carcinoma Using Recurrent SomaticMutations.Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI,Sato Y, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA. Urologic Oncology:Seminars and Original Investigations 2017 Nov 11. Elsevier.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Becerra MF,Reznik E, Redzematovic A, Tennenbaum DM, Ghanaat M, Kashan M, Casuscelli J, Manley BJ, Arcila ME, Carlo MI,Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, and Hsieh JJ. EuropeanUrology Focus. 2017 Oct 20.7. Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma.Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic D, Arcila ME, Tennenbaum DM, GhanaatM, Kashan M, Stief CG, Carlo MI, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, HsiehJJ, Hakimi AA. European Urology Focus. 2017 Sep 23.

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Winer AG,Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, ColemanJA. In Urologic Oncology: Seminars and Original Investigations 2017 Apr 30 (Vol. 35, No. 4, pp. 151-e9). Elsevier.

Secondary pelvic congestion syndrome: description and radiographic diagnosis. Winer AG, Chakiryan NH, MooneyRP, Verges D, Ghanaat M, Allaei A, Robinson L, Zinn H, Lang EK. The Canadian Journal of Urology. 2014Aug;21(4):7365-8.